Form DRS - Draft Registration Statement:
SEC Accession No. 0000950123-21-012961
Filing Date
2021-10-08
Accepted
2021-10-07 21:34:09
Documents
3

Document Format Files

Seq Description Document Type Size
1 filename1.htm DRS 539740
2 GRAPHIC g162874g44t14.jpg GRAPHIC 120064
3 GRAPHIC g162874g92m89.jpg GRAPHIC 66393
  Complete submission text file 0000950123-21-012961.txt   793713
Mailing Address 5858 HORTON STREET #455 EMERYVILLE CA 94608
Business Address 5858 HORTON STREET #455 EMERYVILLE CA 94608 5105052680
4D Molecular Therapeutics Inc. (Filer) CIK: 0001650648 (see all company filings)

EIN.: 473506994 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DRS | Act: 33 | File No.: 377-05573 | Film No.: 211313705
SIC: 2836 Biological Products, (No Diagnostic Substances)